Adicet Bio Inc.

NASDAQ: ACET
Share price (3/28/25): $0.83
Market cap (3/28/25): $68.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Amendment to registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Maltzman Julia D.

Harvey Brian Nicholas

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Termination of Material Definitive Agreement

Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC